Inside Drug Pricing

Orphan Drug IRA Fix Dropped From Senate Text; Medicaid PBM, Pharmacy Measures Remain

By Gabrielle Wanneh / June 16, 2025 at 7:26 PM

The Senate Finance Committee’s newly unveiled reconciliation text scraps a House provision that would expand the number of orphan drugs exempted from Medicare drug price negotiation -- drawing praise from a key drug-price control advocacy group.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

Inside Drug Pricing

Orphan Drug IRA Fix Dropped From Senate Text; Medicaid PBM, Pharmacy Measures Remain

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.